Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution
1 other identifier
observational
100
1 country
1
Brief Summary
Cow's milk protein allergy (CMPA) is often evoked in infants, in particular in front of delayed symptoms such as rectal bleeding, atopic dermatitis, excessive crying, reflux, failure to thrive... But in case of non IgE-mediated CMPA, the only way to diagnose this allergy is to proceed to an elimination-reintroduction test over a period of 2 to 4 weeks, to improve symptoms first, and then provoke them. Even if the diagnosis is confirmed, we speculate that non IgE-mediated CMPA has a faster resolution than other CMPA. The first aim of this study is to estimate the prevalence of non IgE-mediated CMPA in a cohort of infants with delayed symptoms which could be relied to a CMPA. The second goal is evaluate the age of tolerance in non IgE-mediated CMPA with oral food challenge for milk ever 2 months after 4 months of age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
November 26, 2020
CompletedFirst Posted
Study publicly available on registry
December 3, 2020
CompletedDecember 3, 2020
November 1, 2020
Same day
November 26, 2020
November 26, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
prevalence of CMPA in patients with suspicion of non IgE-mediated CMPA
We proceed to an elimination-reintroduction test of the culprit food (CMP) in patients with delayed symptoms of non IgE-mediated CMPA (rectal bleeding, atopic dermatitis, reflux, excessive crying, failure to thrive...) after a period of two to eight weeks of exclusion of CMP. If symptoms disappear after CMP elimination, and reappear after CMP reintroduction, the diagnosis of CMPA is confirmed.
2 to 8 weeks after inclusion
Secondary Outcomes (1)
age of tolerance of confirmed non IgE-mediated CMPA
after 4 months of age, and at least after 2 months of elimination diet, and then ever 2 months until tolerance
Interventions
First oral food challenge after a short period of several weeks of avoidance of CMP to confirm diagnosis of CMPA
Second oral food challenge to test tolerance after 4 months of age if confirmed CMPA
Eligibility Criteria
All infants under 4 months of age consulting for delayed symptoms evoking CMPA are prospectively included. All these infants benefit from a CMP elimination diet by replacing their usual formula with an extensive CMP hydrolysate, hydrolysed rice-protein formula, or an amino acid-based formula (AAF). Only children whose symptoms disappear after this exclusion diet are selected for the study.
You may qualify if:
- infants under 4 months age with delayed symptoms evoking CMPA
You may not qualify if:
- exclusively breastfed infants
- no improvement of symptoms despite amino acid formula
- patients with symptoms of food protein induced enterocolitis
- patients who do not have diagnostic oral food challenge within 3 months after the start of elimination diet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pediatric nutrition and gastroenterology department, Trousseau Hospital, APHP
Paris, 75012, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr, MD
Study Record Dates
First Submitted
November 26, 2020
First Posted
December 3, 2020
Study Start
May 1, 2014
Primary Completion
May 1, 2014
Study Completion
December 1, 2017
Last Updated
December 3, 2020
Record last verified: 2020-11